In this week’s Focus on Health, Dr. Robin Miller shares encouraging research showing that a new gene therapy slowed disease ...

Chris Hemsworth doesn’t give in to fear—or at least it seems that way. The action star spent his childhood adventuring around the Australian outback, and now, he even does some of his own stunts in ...

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion cash, in a deal designed to expand the buyer’s cancer pipeline with Halda’s precision oncology candidates, led by a ...

Community Health System and Valley Children’s Healthcare are leading the charge in Central Valley cancer treatment, bringing advanced cellular and gene therapies — including CAR-T therapy — closer to ...

A major breakthrough in cancer research has shown that using CRISPR gene editing technology to turn off a specific gene can help fight chemotherapy resistance in lung cancer. This discovery could open ...

At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...

The Fellenz family was in court Monday, with Children's Wisconsin, to determine if they had a valid case. "It was dismissed because the judge placed the brain as an organ, and his ruling on organs is ...

The FDA approval of the siRNA drug Redemplo caps off a tumultuous 12 months for Arrowhead, whose partnership with Sarepta caused its own stock to drop during the gene therapy maker’s safety troubles ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

The FDA is adding a Boxed Warning label to delandistrogene moxeparvovec-rokl, a gene therapy for Duchenne muscular dystrophy, after reports of fatal liver injuries.

CAR T-cell therapies have revolutionized blood cancer treatment. Now, researchers with our Human Health Therapeutics Research ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...